Debra Hart | executive |
William Martin | executive |
Kevin Herde | executive |
Matthew Larew | analyst |
Justin Bowers | analyst |
Andrew Burch | executive |
Catherine Ramsey | analyst |
Michael Ryskin | analyst |
Conor Noel McNamara | analyst |
Elizabeth Koslosky | analyst |
Paul Knight | analyst |
Good afternoon, and thank you for standing by. At this time, we would like to welcome everyone to the Q4 2023 Maravai LifeSciences Earnings Conference Call. [Operator Instructions]
I would now like to turn the conference over to Deb Hart, Head of Investor Relations. Please, go ahead.